Tag: atrial fibrillation
Phase 2 trial of AP31969 in patients with atrial fibrillation
Acesion Pharma, a biotech company pioneering treatments for atrial fibrillation, the most common cardiac arrhythmia, has announced enrolment of the first patients in its...
Philips spotlights data-driven cardiology solutions at ESC 2022
Royal Philips, a health technology company, will showcase its latest integrated cardiology solutions at the European Society of Cardiology (ESC) Congress from 26-29 August...
Philips outlines details about BioTel Heart MCOT
Royal Philips conducts a study on ischemic strokes and outlines evolutionary findings in the discipline of cardiovascular diagnosis. Also, they introduced BioTel Heart MCOT...
Abbott to evaluate new device to treat recurrent atrial fibrillation
Abbott announced first enrollments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation (PAF),...